Many recombinant viral vectors for expression of ectopic antigens mimic a natural infection and can induce a robust immune response against certain pathogens and tumors. Host-restricted poxviruses and ...

Downstream purification continues to pressure the biopharmaceutical manufacturing industry from a capacity standpoint, with recent increases in upstream yield and titers overcoming the relatively slow ...

Over the last few years, the number of recombinant pharmaceutical products that have entered the regulatory fray to gain approval for marketing has grown rapidly, and is now in the hundreds. As ...

Osmolality is a well-established parameter for upstream bioprocessing, formulation, analytical development and QC applications throughout the manufacturing of biological drugs. A recent publication ...

Continuous bioprocessing has emerged as a transformative approach in modern biomanufacturing, where integrated upstream and downstream operations enable uninterrupted production of biotherapeutics.

As USDA verification programs and FSMA enforcement continue to place greater emphasis on preventive controls in early 2026, meat and poultry processors are under increasing pressure to demonstrate ...

The inspection technology company continues to find solutions for processors as they face tightening USSDA and FSMA compliance expectations.